MSGERC Town Hall: Optimal Management of Invasive Candidiasis – A live AND ENDURING CME/CPE EVENT

Now Available! Enduring Activity

Case Studies in Optimal Management of Invasive Candidiasis

This multimedia CME/CPE enduring activity from the live MSGERC Town Hall held on July 7, 2023, discusses the newest trends in the management of invasive candidiasis. The expert faculty discuss hospital and health care-associated infection scenarios: a patient coming in from a long-term acute care hospital (LTACH), an invasive fungal infection in a stem cell transplant patient, and an intra-abdominal infection in a hospitalized surgical patient.

Click here to learn more!

Chairs

Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, FECMM, CMQ

Professor of Medicine and Epidemiology
Memorial Hermann Endowed Chair
Vice Chair of Medicine for Healthcare Quality
Chief, Division of Infectious Diseases
McGovern Medical School
Houston, Texas

Luis Ostrosky-Zeichner is a professor of medicine and epidemiology, the vice chair of Medicine for Healthcare Quality, the director of the Laboratory of Mycology Research, and the division chief at the Division of Infectious Diseases of the McGovern Medical School (a part of UTHealth). He also serves as medical director for epidemiology and antimicrobial stewardship for Memorial Hermann Texas Medical Center and UT Physicians. He is also currently coordinating the COVID-19 response for UTHealth and its affiliated hospitals and clinics.

Dr Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Medical School at Houston and MD Anderson Cancer Center combined fellowship program.

Dr Ostrosky-Zeichner is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the Society of Healthcare Epidemiology of America, and the Academy of the European Confederation of Medical Mycology. He is a senior editor for Journal of Antimicrobial Chemotherapy, as well as an editorial board member of Antimicrobial Agents and Chemotherapy and Clinical Infectious Diseases. He is president of the Mycoses Study Group and Educational Consortium and a vice president of the International Immunocompromised Host Society. He is also a past chair of the Infectious Diseases Society of America Standards and Practice Guidelines Committee and has been a consultant to the US FDA and CDC. He has advanced training and experience in medical mycology, healthcare epidemiology, emerging infections, antimicrobial stewardship, general and transplant infectious diseases, and healthcare quality and has published over 175 peer-reviewed articles on those topics.

Peter G. Pappas, MD, FACP

Emeritus Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Alabama School of Medicine
Principal Investigator, Mycoses Study Group
Birmingham, Alabama

Dr Peter G. Pappas is the Emeritus Professor of Medicine in the Division of Infectious Diseases at the University of Alabama in Birmingham (UAB). Dr Pappas was the inaugural William E. Dismukes Professor of Medicine and the first Tinsley Harrison Clinical Scholar at UAB.. Dr. Pappas attended medical school at the University of Alabama at Birmingham, graduating in 1978. He completed his residency in internal medicine, chief medical residency and infectious diseases fellowship at the University of Washington in Seattle. Following completion of his fellowship, he was on the clinical faculty at the University of North Carolina School of Medicine in Chapel Hill, NC, through its affiliated hospital in Wilmington, NC. In 1988, he joined the faculty at the University of Alabama in Birmingham School of Medicine, with a focus on HIV and transplant-associated opportunistic infections, especially the invasive mycoses. His main areas of interest have included the development of new therapies for fungal infections and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. He has performed numerous clinical trials in candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis through his involvement with the National Institute of Allergy and Infectious Diseases’s Bacteriology and Mycology Study Group.

His main areas of interest over the last three decades have included the development of new therapies for fungal infections, fungal diagnostics, and understanding the epidemiology of candidiasis, the endemic mycoses, and cryptococcosis. He has performed numerous clinical trials in candidiasis, cryptococcosis, aspergillosis, sporotrichosis, blastomycosis, and histoplasmosis through his involvement with the NIAID Mycoses Study Group and the MSGERC.

Dr Pappas is Chair of the Scientific Committee of the Mycosis Study Group Education and Research Consortium (MSGERC). He is also the principal investigator for the MSG Central Unit at the University of Alabama in Birmingham from which most MSG clinical trials are administered. He has served as principal investigator of a national network of transplant centers, TRANSNET, in conjunction with the US Centers for Disease Control and Prevention and a consortium of industry co-sponsors to provide important epidemiologic and treatment information to transplant recipients who develop proven and probable invasive fungal infections. More recently, he served as co-PI of the Organ Transplant Infection Detection and Prevention Program (OTIP), a collaborative multicenter group funded by the CDC.

Faculty

Jennifer Cuellar-Rodriguez, MD

Director, Transplant Infectious Diseases Consult Service
Laboratory of Clinical Immunology and Microbiology
Division of Intramural Research
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Bethesda, Maryland

Dr Cuellar Rodriguez received her medical degree from the Universidad Autónoma de Guadalajara (Guadalajara, Mexico) in 1999 and her diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine (London, UK) in 2003. She completed an Internal Medicine residency and Infectious Diseases fellowship at the at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) in Mexico City, followed by a clinical fellowship in Transplant Infectious Diseases at the Cleveland Clinic in Cleveland, OH. In 2009, she joined NIAID as a clinical fellow (visiting program) where she completed an advanced infectious diseases fellowship (academic/research track) in infections in immunocompromised host. She was later promoted to staff clinician in 2011. In 2014, Dr Cuellar Rodriguez returned to the INCMNSZ to serve as head of the Transplant Infectious Diseases Section, within the Department of Infectious Disease, where she remained until 2019. She then returned to NIAID in the Division of Intramural Research and is now the director of the Transplant Infectious Diseases Consult Service.

Jose Vazquez, MD, FACP, FIDSA

Division Chief and Professor of Medicine
Infectious Diseases at Augusta University

Dr Vazquez is the division chief of the Department of Infectious Diseases at Augusta University. He is also a professor of medicine and the chief of the Antimicrobial Stewardship service at AU Health and of the IRB at Augusta University. Prior to this, he was professor of medicine in the Division of Infectious Diseases at Wayne State University School of Medicine and senior staff physician in the Department of Medicine, Division of Infectious Diseases at Henry Ford Hospital and Medical System both in Detroit, Michigan.

Dr Vazquez earned his medical degree from Universidad Católica Madre y Maestra in Santiago, Dominican Republic. He completed both his internship and residency in internal medicine at Finch University of Health Sciences/Chicago Medical School in North Chicago, Illinois. Thereafter, he completed a 3-year Infectious Diseases fellowship at Wayne State University School of Medicine and is board certified in internal medicine and infectious diseases.

Dr Vazquez is a member of several professional societies, including the American College of Physicians, American Society for Microbiology, HIV Medicine Association, Infectious Disease Society of America, International AIDS Society, International Society for Infectious Diseases, International Society for Human and Animal Mycology, and National Foundation for Infectious Diseases, among others. He is a co-principal investigator on an NIH grant evaluating the oral microbiome of HIV-positive subjects. Dr Vazquez has written numerous papers, abstracts, case reports, and book chapters on various infectious disease topics, especially in the area of mycology.

Dr Vazquez’s research includes investigation of the epidemiology and management of mucosal candidiasis, invasive candidiasis, as well as the management of systemic fungal infections. His current research focus also involves characterization of polymicrobial biofilms, especially Candida/Staphylococcus and Aspergillus/Pseudomonas. In addition, he has ongoing clinical interests in chronic wound infections, antifungal susceptibility, antifungal resistance mechanisms and the rapid diagnosis of fungal infections.